BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23861973)

  • 21. GLI2 is a novel therapeutic target for metastasis of osteosarcoma.
    Nagao-Kitamoto H; Nagata M; Nagano S; Kitamoto S; Ishidou Y; Yamamoto T; Nakamura S; Tsuru A; Abematsu M; Fujimoto Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S; Setoguchi T
    Int J Cancer; 2015 Mar; 136(6):1276-84. PubMed ID: 25082385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
    Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L; Zhang G; Lou Z; Xu G; Zhang G
    BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis.
    Zhao H; Guo W; Peng C; Ji T; Lu X
    Mol Biol Rep; 2010 Jun; 37(5):2509-15. PubMed ID: 19701692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer.
    Agyeman A; Mazumdar T; Houghton JA
    Oncotarget; 2012 Aug; 3(8):854-68. PubMed ID: 23097684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide.
    Zhong L; Wang Y; Li W; Gu J; Li X; Wang X; Yue Z; Mu Y; Bai J; Li R; Zhang H
    Mol Cell Biochem; 2014 Jul; 392(1-2):135-44. PubMed ID: 24676542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
    Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
    Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic: a potentially useful poison for Hedgehog-driven cancers.
    Raju GP
    J Clin Invest; 2011 Jan; 121(1):14-6. PubMed ID: 21183780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
    Ghaffari SH; Bashash D; Dizaji MZ; Ghavamzadeh A; Alimoghaddam K
    Tumour Biol; 2012 Feb; 33(1):157-72. PubMed ID: 22072212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment.
    Li XS; Li WQ; Wang WB
    Cancer Biother Radiopharm; 2007 Dec; 22(6):772-8. PubMed ID: 18158768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair.
    Kryeziu K; Jungwirth U; Hoda MA; Ferk F; Knasmüller S; Karnthaler-Benbakka C; Kowol CR; Berger W; Heffeter P
    Mol Cancer Ther; 2013 Jun; 12(6):1073-84. PubMed ID: 23548265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.
    Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R
    Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking signaling at the level of GLI regulates downstream gene expression and inhibits proliferation of canine osteosarcoma cells.
    Shahi MH; Holt R; Rebhun RB
    PLoS One; 2014; 9(5):e96593. PubMed ID: 24810746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In the war against solid tumors arsenic trioxide needs partners.
    Subbarayan PR; Ardalan B
    J Gastrointest Cancer; 2014 Sep; 45(3):363-71. PubMed ID: 24825822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
    Chiu HW; Ho YS; Wang YJ
    J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway.
    Chen MJ; Yang PY; Ye YZ; Hu DN; Chen MF
    Am J Chin Med; 2010; 38(6):1131-42. PubMed ID: 21061466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.